Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Salarius Pharmaceuticals Inc (SLRX)
NASDAQ:SLRX
RESEARCH TOOLSreports
Salarius Pharmaceuticals (SLRX) Stock Price & Analysis
468 Followers
SLRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.41 - $1.81
Previous Close$0.41
Volume25.91K
Average Volume (3M)116.49K
Market Cap
$1.96M
Enterprise Value-$2.31M
Total Cash (Recent Filing)$4.37M
Total Debt (Recent Filing)$100.00K
Price to Earnings (P/E)―
Beta-0.34
Next Earnings
Aug 07, 2024EPS Estimate
-$6.7Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.71
Shares Outstanding4,776,433
10 Day Avg. Volume32,629
30 Day Avg. Volume116,487
Standard Deviation0.25
R-Squared0.05
Alpha-0.08
Financial Highlights & Ratios
Price to Book (P/B)0.54
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.26
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Salarius Pharmaceuticals News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SLRX FAQ
What was Salarius Pharmaceuticals Inc’s price range in the past 12 months?
Salarius Pharmaceuticals Inc lowest stock price was $0.41 and its highest was $1.81 in the past 12 months.
What is Salarius Pharmaceuticals Inc’s market cap?
Currently, no data Available
When is Salarius Pharmaceuticals Inc’s upcoming earnings report date?
Salarius Pharmaceuticals Inc’s upcoming earnings report date is Aug 07, 2024 which is in 57 days.
How were Salarius Pharmaceuticals Inc’s earnings last quarter?
Currently, no data Available
Is Salarius Pharmaceuticals Inc overvalued?
According to Wall Street analysts Salarius Pharmaceuticals Inc’s price is currently Overvalued.
Does Salarius Pharmaceuticals Inc pay dividends?
Salarius Pharmaceuticals Inc does not currently pay dividends.
What is Salarius Pharmaceuticals Inc’s EPS estimate?
Salarius Pharmaceuticals Inc’s EPS estimate is -$6.7.
How many shares outstanding does Salarius Pharmaceuticals Inc have?
Salarius Pharmaceuticals Inc has 4,776,433 shares outstanding.
What happened to Salarius Pharmaceuticals Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Salarius Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in SLRX
---
Salarius Pharmaceuticals Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-76.51%
12-Months-Change
Fundamentals
Return on Equity
-193.68%
Trailing 12-Months
Asset Growth
-51.43%
Trailing 12-Months
Company Description
Salarius Pharmaceuticals Inc
Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company. The firm focuses on the development of Salarius' clinical pipeline, which targets rare, orphan cancers and cancers with a high unmet need. The company is headquartered in Houston, TX.
---
SLRX Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---